Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
CStone Pharmaceuticals Logo
CStone Pharmaceuticals Growth Score
77
CB Rank
40224
Heat Score
71
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Founded
obfuscation
PublicPost-IPO Equity Suzhou, Jiangsu, China101-250 www.cstonepharma.com/
Biotechnology
Health Care
Medical
Pharmaceutical
Overview

CStone Pharmaceuticals
Total Funding
obfuscation
Growth Score
77
Heat Score
71

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score77
-16 pts
in past quarter
Heat Score 71
8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About CStone Pharmaceuticals

CB Rank
40224
CStone Pharmaceuticals is a bio-pharmaceutical company develops new treatments in a range of therapeutic areas.
Founded
obfuscation
PublicPost-IPO Equity Suzhou, Jiangsu, China101-250 www.cstonepharma.com/
Biotechnology
Health Care
Medical
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

  • Photo of Frank Jiang
    Frank Jiang: CEO
  • Photo of Jason Yang
    Jason Yang: CEO，President of R&D and Executive Director
    Past Role: CStone Pharmaceuticals, Founder and Chief Medical Officer

Details

Legal Name CStone Pharmaceuticals Co., Ltd.
Also Known As 基石药业, Jishi Yaoye
Operating Status Active
Stock Symbol  HKG:2616
Company Type For Profit
Founders  Jason Yang
About the Company

CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug

development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.

Phone Number + 86-(0)512-8718-6550
Contact Email cstone@cstonepharma.com
Predictions & Insights

Growth Insight

See this Growth Insight
CStone Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Financial Decline

Products & Services

Sugemalimab (Cejemly®)
An anti-PD-L1 monoclonal antibody for immunotherapy targeting various cancers including non-small cell lung cancer (NSCLC).
Pralsetinib (GAVRETO®)
A selective RET kinase inhibitor for treating RET fusion-positive non-small cell lung cancer and other RET-driven cancers.

Research & Development

CStone Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 5
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Larry Zhao
Larry Zhao
—
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
Photo of Larry Zhao
Larry Zhao
—
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
Photo of Larry Zhao
Larry Zhao
—
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
Photo of Larry Zhao
Larry Zhao
—
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
Photo of Larry Zhao
Larry Zhao
—
Post-IPO Equity - CStone Pharmaceuticals Logo
Post-IPO Equity - CStone Pharmaceuticals
—
Market Intelligence
People
View Profiles & Contacts
Headcount 101-250 Employee Profiles 4 Board Members and Advisors 1 Contacts 10

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 12, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 11, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 10, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

3,257
-10.47%
 in past month

Interest Signals

TopicSurge Score
Machine Ethics Logo
Machine Ethics
90
Portable Document Format (PDF) Logo
Portable Document Format (PDF)
87
Zoom Logo
Zoom
82

Active Website Tech Count

13CStone Pharmaceuticals is actively using 13 technologies for its website, according to BuiltWith. These include Euro, SPF, and  Apache.
Sub-Organizations
Frequently Asked Questions

Where is CStone Pharmaceuticals's headquarters? CStone Pharmaceuticals is located in Suzhou, Jiangsu, China.Who invested in CStone Pharmaceuticals? CStone Pharmaceuticals has 13 investors including Larry Zhao and  Oriza Seed Capital (Oriza Yuandian).When was the last funding round for CStone Pharmaceuticals? CStone Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are CStone Pharmaceuticals's competitors? Alternatives and possible competitors to CStone Pharmaceuticals may include Avenzo Therapeutics, OS Therapies, and  Merck.How much funding has CStone Pharmaceuticals raised to date? CStone Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(d4095e5 1)
|